ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Isolated Lung Perfusion System Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: October 2025
|
Report Code: QYRE-Auto-14N17508
Home | Market Reports | Health| Medical Devices & Equipment
Global Isolated Lung Perfusion System Market Research Report 2024
BUY CHAPTERS

Global Isolated Lung Perfusion System Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-14N17508
Report
October 2025
Pages:136
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Harvard Apparatus
Transmedics
Bridge to Life
Radnoti
XVIVO
ALCOTT BIOTECH

Isolated Lung Perfusion System Market

The global Isolated Lung Perfusion System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Isolated lung perfusion system is a specialized apparatus used in experimental research to perfuse and study the function of isolated lungs ex vivo. This system allows for the controlled delivery of oxygenated perfusate to the lung, mimicking physiological conditions outside the body. Researchers use the Isolated Lung Perfusion System to investigate lung physiology, evaluate the effects of drugs or treatments on lung function, and develop new therapies for respiratory diseases.
From a downstream perspective, Drug Testing accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Isolated Lung Perfusion System leading manufacturers including Harvard Apparatus, Transmedics, Bridge to Life, Radnoti, ALCOTT BIOTECH, XVIVO, etc., dominate supply; the top five capture approximately % of global revenue, with Harvard Apparatus leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Isolated Lung Perfusion System market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Isolated Lung Perfusion System Market Report

Report Metric Details
Report Name Isolated Lung Perfusion System Market
Segment by Type
Segment by Application
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Harvard Apparatus, Transmedics, Bridge to Life, Radnoti, ALCOTT BIOTECH, XVIVO
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Isolated Lung Perfusion System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Isolated Lung Perfusion System Market report?

Ans: The main players in the Isolated Lung Perfusion System Market are Harvard Apparatus, Transmedics, Bridge to Life, Radnoti, ALCOTT BIOTECH, XVIVO

What are the Application segmentation covered in the Isolated Lung Perfusion System Market report?

Ans: The Applications covered in the Isolated Lung Perfusion System Market report are Drug Testing, Toxicology Testing, Lung Transplant, Others

What are the Type segmentation covered in the Isolated Lung Perfusion System Market report?

Ans: The Types covered in the Isolated Lung Perfusion System Market report are Animal Isolated Lung Perfusion System, Human Isolated Lung Perfusion System

Recommended Reports

Perfusion Devices Market

Respiratory Therapy Devices

Lung and Thoracic Solutions

1 Study Coverage
1.1 Introduction to Isolated Lung Perfusion System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Isolated Lung Perfusion System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Animal Isolated Lung Perfusion System
1.2.3 Human Isolated Lung Perfusion System
1.3 Market Segmentation by Application
1.3.1 Global Isolated Lung Perfusion System Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Drug Testing
1.3.3 Toxicology Testing
1.3.4 Lung Transplant
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Isolated Lung Perfusion System Revenue Estimates and Forecasts 2020-2031
2.2 Global Isolated Lung Perfusion System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Isolated Lung Perfusion System Sales Estimates and Forecasts 2020-2031
2.4 Global Isolated Lung Perfusion System Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Isolated Lung Perfusion System Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Isolated Lung Perfusion System Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Animal Isolated Lung Perfusion System Market Size by Manufacturers
3.5.2 Human Isolated Lung Perfusion System Market Size by Manufacturers
3.6 Global Isolated Lung Perfusion System Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Isolated Lung Perfusion System Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Isolated Lung Perfusion System Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Isolated Lung Perfusion System Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Isolated Lung Perfusion System Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Isolated Lung Perfusion System Sales and Revenue by Type (2020-2031)
6.4 North America Isolated Lung Perfusion System Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Isolated Lung Perfusion System Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Isolated Lung Perfusion System Sales and Revenue by Type (2020-2031)
7.4 Europe Isolated Lung Perfusion System Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Isolated Lung Perfusion System Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Isolated Lung Perfusion System Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Isolated Lung Perfusion System Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Isolated Lung Perfusion System Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Isolated Lung Perfusion System Sales and Revenue by Type (2020-2031)
9.4 Central and South America Isolated Lung Perfusion System Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Isolated Lung Perfusion System Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Isolated Lung Perfusion System Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Isolated Lung Perfusion System Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Isolated Lung Perfusion System Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Harvard Apparatus
11.1.1 Harvard Apparatus Corporation Information
11.1.2 Harvard Apparatus Business Overview
11.1.3 Harvard Apparatus Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.1.4 Harvard Apparatus Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Harvard Apparatus Isolated Lung Perfusion System Sales by Product in 2024
11.1.6 Harvard Apparatus Isolated Lung Perfusion System Sales by Application in 2024
11.1.7 Harvard Apparatus Isolated Lung Perfusion System Sales by Geographic Area in 2024
11.1.8 Harvard Apparatus Isolated Lung Perfusion System SWOT Analysis
11.1.9 Harvard Apparatus Recent Developments
11.2 Transmedics
11.2.1 Transmedics Corporation Information
11.2.2 Transmedics Business Overview
11.2.3 Transmedics Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.2.4 Transmedics Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Transmedics Isolated Lung Perfusion System Sales by Product in 2024
11.2.6 Transmedics Isolated Lung Perfusion System Sales by Application in 2024
11.2.7 Transmedics Isolated Lung Perfusion System Sales by Geographic Area in 2024
11.2.8 Transmedics Isolated Lung Perfusion System SWOT Analysis
11.2.9 Transmedics Recent Developments
11.3 Bridge to Life
11.3.1 Bridge to Life Corporation Information
11.3.2 Bridge to Life Business Overview
11.3.3 Bridge to Life Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.3.4 Bridge to Life Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Bridge to Life Isolated Lung Perfusion System Sales by Product in 2024
11.3.6 Bridge to Life Isolated Lung Perfusion System Sales by Application in 2024
11.3.7 Bridge to Life Isolated Lung Perfusion System Sales by Geographic Area in 2024
11.3.8 Bridge to Life Isolated Lung Perfusion System SWOT Analysis
11.3.9 Bridge to Life Recent Developments
11.4 Radnoti
11.4.1 Radnoti Corporation Information
11.4.2 Radnoti Business Overview
11.4.3 Radnoti Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.4.4 Radnoti Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Radnoti Isolated Lung Perfusion System Sales by Product in 2024
11.4.6 Radnoti Isolated Lung Perfusion System Sales by Application in 2024
11.4.7 Radnoti Isolated Lung Perfusion System Sales by Geographic Area in 2024
11.4.8 Radnoti Isolated Lung Perfusion System SWOT Analysis
11.4.9 Radnoti Recent Developments
11.5 ALCOTT BIOTECH
11.5.1 ALCOTT BIOTECH Corporation Information
11.5.2 ALCOTT BIOTECH Business Overview
11.5.3 ALCOTT BIOTECH Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.5.4 ALCOTT BIOTECH Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 ALCOTT BIOTECH Isolated Lung Perfusion System Sales by Product in 2024
11.5.6 ALCOTT BIOTECH Isolated Lung Perfusion System Sales by Application in 2024
11.5.7 ALCOTT BIOTECH Isolated Lung Perfusion System Sales by Geographic Area in 2024
11.5.8 ALCOTT BIOTECH Isolated Lung Perfusion System SWOT Analysis
11.5.9 ALCOTT BIOTECH Recent Developments
11.6 XVIVO
11.6.1 XVIVO Corporation Information
11.6.2 XVIVO Business Overview
11.6.3 XVIVO Isolated Lung Perfusion System Product Models, Descriptions and Specifications
11.6.4 XVIVO Isolated Lung Perfusion System Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 XVIVO Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Isolated Lung Perfusion System Industry Chain
12.2 Isolated Lung Perfusion System Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Isolated Lung Perfusion System Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Isolated Lung Perfusion System Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Isolated Lung Perfusion System Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Isolated Lung Perfusion System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Harvard Apparatus
Transmedics
Bridge to Life
Radnoti
XVIVO
ALCOTT BIOTECH
List of Tables
 Table 1. Global Isolated Lung Perfusion System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Isolated Lung Perfusion System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Isolated Lung Perfusion System Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Isolated Lung Perfusion System Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Isolated Lung Perfusion System Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Isolated Lung Perfusion System Sales by Region (2020-2025) & (Units)
 Table 8. Global Isolated Lung Perfusion System Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Isolated Lung Perfusion System Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Isolated Lung Perfusion System Sales Share by Manufacturers (2020-2025)
 Table 12. Global Isolated Lung Perfusion System Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Isolated Lung Perfusion System Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Isolated Lung Perfusion System by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isolated Lung Perfusion System as of 2024)
 Table 16. Global Isolated Lung Perfusion System Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Isolated Lung Perfusion System Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Isolated Lung Perfusion System Manufacturing Base and Headquarters
 Table 19. Global Isolated Lung Perfusion System Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Isolated Lung Perfusion System Sales by Type (2020-2025) & (Units)
 Table 23. Global Isolated Lung Perfusion System Sales by Type (2026-2031) & (Units)
 Table 24. Global Isolated Lung Perfusion System Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Isolated Lung Perfusion System Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Isolated Lung Perfusion System ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Isolated Lung Perfusion System Sales by Application (2020-2025) & (Units)
 Table 29. Global Isolated Lung Perfusion System Sales by Application (2026-2031) & (Units)
 Table 30. Isolated Lung Perfusion System High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Isolated Lung Perfusion System Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Isolated Lung Perfusion System Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Isolated Lung Perfusion System ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Isolated Lung Perfusion System Growth Accelerators and Market Barriers
 Table 37. North America Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Isolated Lung Perfusion System Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Isolated Lung Perfusion System Growth Accelerators and Market Barriers
 Table 40. Europe Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Isolated Lung Perfusion System Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Isolated Lung Perfusion System Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Isolated Lung Perfusion System Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Isolated Lung Perfusion System Investment Opportunities and Key Challenges
 Table 47. Central and South America Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Isolated Lung Perfusion System Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Isolated Lung Perfusion System Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Harvard Apparatus Corporation Information
 Table 51. Harvard Apparatus Description and Major Businesses
 Table 52. Harvard Apparatus Product Models, Descriptions and Specifications
 Table 53. Harvard Apparatus Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Harvard Apparatus Sales Value Proportion by Product in 2024
 Table 55. Harvard Apparatus Sales Value Proportion by Application in 2024
 Table 56. Harvard Apparatus Sales Value Proportion by Geographic Area in 2024
 Table 57. Harvard Apparatus Isolated Lung Perfusion System SWOT Analysis
 Table 58. Harvard Apparatus Recent Developments
 Table 59. Transmedics Corporation Information
 Table 60. Transmedics Description and Major Businesses
 Table 61. Transmedics Product Models, Descriptions and Specifications
 Table 62. Transmedics Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Transmedics Sales Value Proportion by Product in 2024
 Table 64. Transmedics Sales Value Proportion by Application in 2024
 Table 65. Transmedics Sales Value Proportion by Geographic Area in 2024
 Table 66. Transmedics Isolated Lung Perfusion System SWOT Analysis
 Table 67. Transmedics Recent Developments
 Table 68. Bridge to Life Corporation Information
 Table 69. Bridge to Life Description and Major Businesses
 Table 70. Bridge to Life Product Models, Descriptions and Specifications
 Table 71. Bridge to Life Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Bridge to Life Sales Value Proportion by Product in 2024
 Table 73. Bridge to Life Sales Value Proportion by Application in 2024
 Table 74. Bridge to Life Sales Value Proportion by Geographic Area in 2024
 Table 75. Bridge to Life Isolated Lung Perfusion System SWOT Analysis
 Table 76. Bridge to Life Recent Developments
 Table 77. Radnoti Corporation Information
 Table 78. Radnoti Description and Major Businesses
 Table 79. Radnoti Product Models, Descriptions and Specifications
 Table 80. Radnoti Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. Radnoti Sales Value Proportion by Product in 2024
 Table 82. Radnoti Sales Value Proportion by Application in 2024
 Table 83. Radnoti Sales Value Proportion by Geographic Area in 2024
 Table 84. Radnoti Isolated Lung Perfusion System SWOT Analysis
 Table 85. Radnoti Recent Developments
 Table 86. ALCOTT BIOTECH Corporation Information
 Table 87. ALCOTT BIOTECH Description and Major Businesses
 Table 88. ALCOTT BIOTECH Product Models, Descriptions and Specifications
 Table 89. ALCOTT BIOTECH Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. ALCOTT BIOTECH Sales Value Proportion by Product in 2024
 Table 91. ALCOTT BIOTECH Sales Value Proportion by Application in 2024
 Table 92. ALCOTT BIOTECH Sales Value Proportion by Geographic Area in 2024
 Table 93. ALCOTT BIOTECH Isolated Lung Perfusion System SWOT Analysis
 Table 94. ALCOTT BIOTECH Recent Developments
 Table 95. XVIVO Corporation Information
 Table 96. XVIVO Description and Major Businesses
 Table 97. XVIVO Product Models, Descriptions and Specifications
 Table 98. XVIVO Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. XVIVO Recent Developments
 Table 100. Key Raw Materials Distribution
 Table 101. Raw Materials Key Suppliers
 Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 103. Milestones in Production Technology Evolution
 Table 104. Distributors List
 Table 105. Market Trends and Market Evolution
 Table 106. Market Drivers and Opportunities
 Table 107. Market Challenges, Risks, and Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources


List of Figures
 Figure 1. Isolated Lung Perfusion System Product Picture
 Figure 2. Global Isolated Lung Perfusion System Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Animal Isolated Lung Perfusion System Product Picture
 Figure 4. Human Isolated Lung Perfusion System Product Picture
 Figure 5. Global Isolated Lung Perfusion System Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Drug Testing
 Figure 7. Toxicology Testing
 Figure 8. Lung Transplant
 Figure 9. Others
 Figure 10. Isolated Lung Perfusion System Report Years Considered
 Figure 11. Global Isolated Lung Perfusion System Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Isolated Lung Perfusion System Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Isolated Lung Perfusion System Revenue Market Share by Region (2020-2031)
 Figure 15. Global Isolated Lung Perfusion System Sales (2020-2031) & (Units)
 Figure 16. Global Isolated Lung Perfusion System Sales (CAGR) by Region (2020-2031) (Units)
 Figure 17. Global Isolated Lung Perfusion System Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Isolated Lung Perfusion System Sales Volume Market Share in 2024
 Figure 19. Global Isolated Lung Perfusion System Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Animal Isolated Lung Perfusion System Revenue Market Share by Manufacturer in 2024
 Figure 22. Human Isolated Lung Perfusion System Revenue Market Share by Manufacturer in 2024
 Figure 23. Global Isolated Lung Perfusion System Sales Market Share by Type (2020-2031)
 Figure 24. Global Isolated Lung Perfusion System Revenue Market Share by Type (2020-2031)
 Figure 25. Global Isolated Lung Perfusion System Sales Market Share by Application (2020-2031)
 Figure 26. Global Isolated Lung Perfusion System Revenue Market Share by Application (2020-2031)
 Figure 27. North America Isolated Lung Perfusion System Sales YoY (2020-2031) & (Units)
 Figure 28. North America Isolated Lung Perfusion System Revenue YoY (2020-2031) & (US$ Million)
 Figure 29. North America Top 5 Manufacturers Isolated Lung Perfusion System Sales Revenue (US$ Million) in 2024
 Figure 30. North America Isolated Lung Perfusion System Sales Volume (Units) by Type (2020- 2031)
 Figure 31. North America Isolated Lung Perfusion System Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 32. North America Isolated Lung Perfusion System Sales Volume (Units) by Application (2020-2031)
 Figure 33. North America Isolated Lung Perfusion System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 34. US Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 35. Canada Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 36. Mexico Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 37. Europe Isolated Lung Perfusion System Sales YoY (2020-2031) & (Units)
 Figure 38. Europe Isolated Lung Perfusion System Revenue YoY (2020-2031) & (US$ Million)
 Figure 39. Europe Top 5 Manufacturers Isolated Lung Perfusion System Sales Revenue (US$ Million) in 2024
 Figure 40. Europe Isolated Lung Perfusion System Sales Volume (Units) by Type (2020-2031)
 Figure 41. Europe Isolated Lung Perfusion System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 42. Europe Isolated Lung Perfusion System Sales Volume (Units) by Application (2020-2031)
 Figure 43. Europe Isolated Lung Perfusion System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 44. Germany Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 45. France Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 46. U.K. Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 47. Italy Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 48. Russia Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Isolated Lung Perfusion System Sales YoY (2020-2031) & (Units)
 Figure 50. Asia-Pacific Isolated Lung Perfusion System Revenue YoY (2020-2031) & (US$ Million)
 Figure 51. Asia-Pacific Top 8 Manufacturers Isolated Lung Perfusion System Sales Revenue (US$ Million) in 2024
 Figure 52. Asia-Pacific Isolated Lung Perfusion System Sales Volume (Units) by Type (2020- 2031)
 Figure 53. Asia-Pacific Isolated Lung Perfusion System Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 54. Asia-Pacific Isolated Lung Perfusion System Sales Volume (Units) by Application (2020-2031)
 Figure 55. Asia-Pacific Isolated Lung Perfusion System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 56. Indonesia Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 57. Japan Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 58. South Korea Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 59. China Taiwan Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 60. India Isolated Lung Perfusion System Revenue (2020-2031) & (US$ Million)
 Figure 61. Central and South America Isolated Lung Perfusion System Sales YoY (2020-2031) & (Units)
 Figure 62. Central and South America Isolated Lung Perfusion System Revenue YoY (2020-2031) & (US$ Million)
 Figure 63. Central and South America Top 5 Manufacturers Isolated Lung Perfusion System Sales Revenue (US$ Million) in 2024
 Figure 64. Central and South America Isolated Lung Perfusion System Sales Volume (Units) by Type (2021-2031)
 Figure 65. Central and South America Isolated Lung Perfusion System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 66. Central and South America Isolated Lung Perfusion System Sales Volume (Units) by Application (2020-2031)
 Figure 67. Central and South America Isolated Lung Perfusion System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 68. Brazil Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
 Figure 69. Argentina Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
 Figure 70. Middle East, and Africa Isolated Lung Perfusion System Sales YoY (2020-2031) & (Units)
 Figure 71. Middle East and Africa Isolated Lung Perfusion System Revenue YoY (2020-2031) & (US$ Million)
 Figure 72. Middle East and Africa Top 5 Manufacturers Isolated Lung Perfusion System Sales Revenue (US$ Million) in 2024
 Figure 73. Middle East and Africa Isolated Lung Perfusion System Sales Volume (Units) by Type (2021-2031)
 Figure 74. South America Isolated Lung Perfusion System Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 75. Middle East and Africa Isolated Lung Perfusion System Sales Volume (Units) by Application (2020-2031)
 Figure 76. Middle East and Africa Isolated Lung Perfusion System Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 77. GCC Countries Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
 Figure 78. Turkey Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
 Figure 79. Egypt Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
 Figure 80. South Africa Isolated Lung Perfusion System Revenue (2020-2025) & (US$ Million)
 Figure 81. Isolated Lung Perfusion System Industry Chain Mapping
 Figure 82. Regional Isolated Lung Perfusion System Manufacturing Base Distribution (%)
 Figure 83. Global Isolated Lung Perfusion System Production Market Share by Region (2020-2031)
 Figure 84. Isolated Lung Perfusion System Production Process
 Figure 85. Regional Isolated Lung Perfusion System Production Cost Structure
 Figure 86. Channels of Distribution (Direct Vs Distribution)
 Figure 87. Bottom-up and Top-down Approaches for This Report
 Figure 88. Data Triangulation
 Figure 89. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Isolated Heart Perfusion System Market Research Report 2024
Global Langendorff Isolated Heart Perfusion System Market Research Report 2024
Preclinical Isolated Organ Perfusion System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Automated Perfusion System Market Research Report 2025
Global Organ Perfusion System Market Research Report 2024
Global Advanced Perfusion System Market Research Report 2024
Global Perfusion Transporter Market Research Report 2024
Global Perfusion Culture System Market Research Report 2025
Global Organ Mechanical Perfusion Systems and Consumables Market Research Report 2024
Global Single Cell Isolation System Market Research Report 2024
Global Machine Perfusion System Market Research Report 2024
Global Organ Mechanical Perfusion System Consumables Market Research Report 2024
Global Lung Simulators Market Research Report 2024
Global Pet Organ Infusion System Market Research Report 2024
Global Organ Mechanical Perfusion Box Market Research Report 2024
Global Organ Perfusion and Preservation Market Research Report 2024
Cell Perfusion Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Perfusion Services Market Research Report 2024
Global Constant Temperature Perfusion Device for Isolated Tissues and Organs Market Research Report 2025
Global Warm Blood Perfusion System Market Research Report 2024

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37F12574
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15J20209
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8O12834
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-36J12622
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions